Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1487)	1/5/2006 4:16:01 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

SGEN Was up 14.66% when it traded at 5.24 at 2.06PM and 3.58PM It also announced today that its CEO will present at the 24th Annual JPMorgan Healthcare Conference on Jan.12 The stock needs to close above its Dec.13 H of 5.32 in oredr to test its more important resistance from its Oct.-Nov H at 5.79 bigcharts.marketwatch.com SGEN Has reported better revenues in the last 3Qs and has been trimming its loss.(The estimated loss for this year is around $0.70/shr vs. the $1.80/shr in 2004 ) On Dec.12 it reported results of its PI on SGN-40 in MM and non-Hodgkin's lymphoma at the ASH meeting which showed that the drug is well tolerated and has antitumor activity. Bernard